These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Uterine leiomyosarcoma arising in leiomyoma: clinicopathological study of four cases and literature review. Yanai H, Wani Y, Notohara K, Takada S, Yoshino T. Pathol Int; 2010 Jul; 60(7):506-9. PubMed ID: 20594271 [Abstract] [Full Text] [Related]
4. The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors. Atkins KA, Arronte N, Darus CJ, Rice LW. Am J Surg Pathol; 2008 Jan; 32(1):98-102. PubMed ID: 18162776 [Abstract] [Full Text] [Related]
5. Expression of Ki-67, P53 and progesterone receptors in uterine smooth muscle tumors. Diagnostic value. Petrović D, Babić D, Forko JI, Martinac I. Coll Antropol; 2010 Mar; 34(1):93-7. PubMed ID: 20437637 [Abstract] [Full Text] [Related]
6. Prognostic value of von Willebrand factor, CD34, CD31, and vascular endothelial growth factor expression in women with uterine leiomyosarcomas. Poncelet C, Fauvet R, Feldmann G, Walker F, Madelenat P, Darai E. J Surg Oncol; 2004 May 01; 86(2):84-90. PubMed ID: 15112250 [Abstract] [Full Text] [Related]
10. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors. Sgantzos MN, Galani V, Arvanitis LD, Charchanti A, Psathas P, Nakou M, Havaki S, Kallioras V, Marinos E, Vamvakopoulos NC, Kittas C. Pathol Res Pract; 2007 May 01; 203(1):31-7. PubMed ID: 17129677 [Abstract] [Full Text] [Related]
11. Cell cycle regulatory markers in uterine atypical leiomyoma and leiomyosarcoma: immunohistochemical study of 68 cases with clinical follow-up. Mills AM, Ly A, Balzer BL, Hendrickson MR, Kempson RL, McKenney JK, Longacre TA. Am J Surg Pathol; 2013 May 01; 37(5):634-42. PubMed ID: 23552380 [Abstract] [Full Text] [Related]
12. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma. Bodner K, Bodner-Adler B, Kimberger O, Czerwenka K, Mayerhofer K. J Soc Gynecol Investig; 2004 Apr 01; 11(3):187-91. PubMed ID: 15051039 [Abstract] [Full Text] [Related]
15. Atypical leiomyomas of the uterus with long-term follow-up after myomectomy with immunohistochemical analysis for p16INK4A, p53, Ki-67, estrogen receptors, and progesterone receptors. Sung CO, Ahn G, Song SY, Choi YL, Bae DS. Int J Gynecol Pathol; 2009 Nov 01; 28(6):529-34. PubMed ID: 19851199 [Abstract] [Full Text] [Related]
16. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Leitao MM, Soslow RA, Nonaka D, Olshen AB, Aghajanian C, Sabbatini P, Dupont J, Hensley M, Sonoda Y, Barakat RR, Anderson S. Cancer; 2004 Sep 15; 101(6):1455-62. PubMed ID: 15316901 [Abstract] [Full Text] [Related]